Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
60 participants
OBSERVATIONAL
2023-10-31
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Treatment Response in Breast Cancer Related Lymphedema
NCT04766489
Effectiveness of Stellate Ganglion Block in Breast Cancer Related Lymphedema
NCT04165512
Ultrasonographic Evaluation of Changes After Complex Decongestive Therapy
NCT04139291
Multi-Parametric Assessment of Breast Lymphedema
NCT02724514
Assessment of Muscle Strength and Volume Changes in Patients With Breast Cancer- Related Lymphedema
NCT03945838
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Group 1: CDT Group 2: CDT + PO ketoprofen +Local ketoprofen gel Group 3: CDT + Local ketoprofen gel
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Complete Decongestive Therapy
No interventions assigned to this group
Group 2
Complete Decongestive Therapy + PO Ketoprofen + Local ketoprofen gel
Ketoprofen
PO and local therapy
Group 3
Complete Decongestive Therapy + Local Ketoprofen gel
Ketoprofen
PO and local therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ketoprofen
PO and local therapy
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Lymphedema more than 6 months
* Lymphedema stage 0-2
* Completed treatment (CT-RT)
Exclusion Criteria
* Cardiovasculary disease
* Hepatic disease
* Kidney disease
* Cerebrovascular event
* Metastasis
* Gastritis
* Infection
* Smoking
* Active cancer
* Bleeding history
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Turkish Lymphedema Society
UNKNOWN
The Breast Health Society, Turkey
OTHER
Ege University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sibel Eyigor
MD, Prof
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Atilla Soran
Role: STUDY_CHAIR
University of Pittsburgh Medical Center
References
Explore related publications, articles, or registry entries linked to this study.
Forte AJ, Boczar D, Huayllani MT, Lu X, McLaughlin SA. Pharmacotherapy Agents in Lymphedema Treatment: A Systematic Review. Cureus. 2019 Dec 5;11(12):e6300. doi: 10.7759/cureus.6300.
Rockson SG, Tian W, Jiang X, Kuznetsova T, Haddad F, Zampell J, Mehrara B, Sampson JP, Roche L, Kim J, Nicolls MR. Pilot studies demonstrate the potential benefits of antiinflammatory therapy in human lymphedema. JCI Insight. 2018 Oct 18;3(20):e123775. doi: 10.1172/jci.insight.123775.
Nakamura K, Radhakrishnan K, Wong YM, Rockson SG. Anti-inflammatory pharmacotherapy with ketoprofen ameliorates experimental lymphatic vascular insufficiency in mice. PLoS One. 2009 Dec 21;4(12):e8380. doi: 10.1371/journal.pone.0008380.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LET
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.